Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Supplement—December 2022

Use of Project ECHO in Response to COVID-19 in Countries Supported by US President’s Emergency Plan for AIDS Relief

Janell WrightComments to Author , Laura Tison, Helen Chun, Cristine Gutierrez, Mariangeli Freitas Ning, Rosa Elena Morales, Beatriz Lopez, James Simpungwe, Kenneth Masamaro, Nazira Usmanova, Gram Mutandi, Sudhir Bunga, and Simon Agolory
Author affiliations: US Centers for Disease Control and Prevention, Guatemala City, Guatemala (J. Wright, C. Gutierrez, M. Freitas Ning, R.E. Morales, B. Lopez); US Centers for Disease Control and Prevention, Atlanta, Georgia, USA (L. Tison, H. Chun); US Centers for Disease Control and Prevention, Lusaka, Zambia (J. Simpungwe, S. Agolory); US Centers for Disease Control and Prevention, Nairobi, Kenya (K. Masamaro); US Centers for Disease Control and Prevention, Bishkek, Kyrgyzstan (N. Usmanova); US Centers for Disease Control and Prevention, Windhoek, Namibia (G. Mutandi); US Centers for Disease Control and Prevention, Juba, South Sudan (S. Bunga)

Main Article

Table 3

Topics, gaps and participant concerns and questions in COVID-19 Project ECHO sessions conducted in countries supported by US President’s Emergency Plan for AIDS Relief, 2020–2021*

Topics covered Gaps identified by participants Examples of main concerns and common questions
COVID-19 case management
1) Principles of oxygen escalation/de-escalation; 2) innovative therapies for mild/moderate cases
1) What parameters are used in the decision to use supportive oxygen?; 2) mild/moderate COVID-19 case management; 3) how long does immunity to COVID-19 last?
Co-infection and comorbidities
1) Warning signs and management of cardiovascular manifestations of COVID-19; 2) management of patients with hypertension and COVID-19; 3) COVID-19 management in patients with comorbidities
1) How to standardize treatment for patients; 2) the role of steroid management in COVID-19 management
Infection prevention and control, PPE
1) PPE principles and use/reuse scenarios; 2) infection prevention and control in the context of community service delivery; 3) SARS-CoV-2 modes of transmission
1) Principles of donning and doffing PPE for frontline HCWs and standards for reuse in resource-limited settings; 2) mask use according to clinical service delivery points; 3) community behavior change strategies in infection prevention
1) Vaccine development processes and mechanisms of action; 2) COVID-19 vaccine demand creation strategies
1) Vaccination guidance for pregnant patients, other vulnerable populations, and persons previously infected with COVID-19; 2) management and reporting of vaccine-related adverse events during vaccination campaigns
Mental health
1) Specialists available and equipped to address HCW needs; 2) strategies to address mental health issues and build resilience among front-line HCW
1) Addressing mental health needs of HCWs during the pandemic; 2) HCW support systems and lack thereof; 3) insufficient expertise in diagnosing Mental Health issues leading to a growing number of undiagnosed health issues
1) SARS-CoV-2 surveillance methods and best practices; 2) acute febrile disease surveillance in a COVID-19 pandemic
1) Role of community health workers for COVID-19 disease surveillance; 2) harnessing digital technologies to improve Health Information systems
Laboratory 1) Role of public health laboratories in the pandemic response; 2) SARS-CoV-2 detection kit evaluation and validation; 3) SARS-CoV-2 diagnostic testing expansion and decentralization 1) Diagnostic test result (molecular and antigen) interpretation; 2) COVID-19 test positivity and duration of infectivity?; 3) serologic tests’ utility in the diagnosis of acute COVID-19

*ECHO, Extension for Community Healthcare Outcomes; HCW, healthcare worker; PPE, personal protective equipment.

Main Article

Page created: October 15, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.